# Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)

> **NCT01096732** · PHASE2 · TERMINATED · sponsor: **Lisa Bax** · enrollment: 3 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** GDC-0449

## Key facts

- **NCT ID:** NCT01096732
- **Lead sponsor:** Lisa Bax
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2014-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096732, "Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01096732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*